LifeVantage Announces Intent to Launch Protandim Nrf1 Synergizer Product

Company to expand Protandim product line to include Nrf1 and Nrf2 Synergizer products that work synergistically to naturally reduce cellular stress

SALT LAKE CITY, Feb. 19, 2016 -- LifeVantage Corporation (Nasdaq:LFVN), has announced its intent to launch Protandim Nrf1 Synergizer moments ago during its Elite Academy in Nashville, TN. The company intends to host a live cyber-launch in the fourth quarter of fiscal 2016 that will broadcast worldwide through the company’s website.

“We will continue to strategically introduce new products that align with our objective to have a cohesive product offering that is unique and exclusive to LifeVantage, and provides optimal health for everyone,” said LifeVantage President and Chief Executive Officer, Darren Jensen. “The Protandim NFR1 Synergizer is formulated to strengthen the mitochondria, which are the power house of all cells for better cellular health. It is designed to work in tandem with our flagship Protandim Nrf2 Synergizer product and further enhance our body’s ability to naturally produce antioxidants and reduce the effects of cellular stress on its own.” Jensen continues, “Our advances in Nrf1 and Nrf2 Synergizer science continues to position LifeVantage on the leading-edge of Nutrigenomics.”

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq:LFVN), is a science based network marketing company dedicated to visionary science that looks to transform health, wellness and anti-aging internally and externally at the cellular level. The company is the maker of Protandim®, the Nrf2 Synergizer® patented dietary supplement, the TrueScience™ Anti-Aging Skin Care Regimen, Canine Health, the AXIO™ energy product line and the PhysIQ™ smart weight management system. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah.

Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe", "hopes", "intends", "estimates", "expects", "projects", "plans", "anticipates", "look forward to", “goal”, “ideal fit”, and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements we make regarding our leadership in the global market, future growth and financial performance. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.

Company Relations Contact: 
John Genna (801) 432-9172
Vice President of Communications 
& Corporate Partnerships

Investor Relations Contact:
Cindy England (801) 432-9036
Director of Investor Relations
-or-
John Mills (646) 277-1254
Partner, ICR INC
-or-
Scott Van Winkle (617) 956-6736
Managing Director, ICR INC